Innovation in Atrial Fibrillation Treatment and the Paradox of Regional Disparity

Figures

• 

  Central Figure.

• 

  Figure 1.. The threat of atrial fibrillation (AF) and advances in catheter ablation (CA) technology. The globally aging population is exponentially increasing the incidence of AF, a major public health issue and a disease with a poor prognosis that causes stroke and heart failure, even leading to death in the oldest-older patients. CA has dramatically advanced as a curative treatment, evolving into a primary therapeutic option. Continuous technological progress in CA, including device innovations such as pulsed field ablation, improves the quality of AF treatment and is evaluated as a welcome advancement that fulfills the medical mission of saving more patients.

• 

  Figure 2.. Regional disparity in atrial fibrillation treatment. Catheter ablation (CA) technology has rapidly advanced, but equitable dissemination is crucial for its benefits to reach the wider population. The reality, however, is a concentration of innovation in limited areas, resulting in severe regional disparities (the paradox of technological innovation). The mean number of ablation procedures per 10,000 population across the 47 prefectures was 6.67 (95% CI: 6.19–7.12), with a maximum of 9.24 and a minimum of 3.02 procedures. This figure, partially excerpted and illustrated from the authors’ previously published work in Circulation Reports, clearly demonstrates the domestic regional disparity in the number of CA procedures performed in Japan. The analysis presented here utilizes data previously collected by the authors and secondarily derived from a study already published in Circulation Reports.9 Permission from all authors was obtained for the replication and processing of the source data. The horizontal axis indicates the number of ablation procedures performed in each prefecture in 2022, per 10,000 population. This dataset was constructed using data from the Vital Statistics…

• 

  Figure 3.. Paradigm shift for disparity correction: reallocation of commitment and scientific approach. Amid the rapid technological advancements in catheter ablation (CA), a paradigm shift is required for clinicians and researchers to redirect their commitment and effort toward addressing the social challenge of equitably and widely disseminating treatment benefits. Achieving the principle of “saving always one more patient” requires channeling commitment to new technology into the greater goal of tackling health disparity with a scientific approach. The key to eliminating treatment inequity lies in the commitment of healthcare professionals who bear this professional and societal responsibility, supported by the resulting accumulation of scientific and policy-oriented data.